For example, in colorectal carcinoma models, combining oxaliplatin with ATR inhibition and anti-PD-1 therapy significantly decreased neutrophil infiltration and facilitated the expansion of stem-like, IFN-γ–producing CD8+ T cells, resulting in complete tumor regression [123]. The gene discussed is CD8A; the disease is neoplasm.